Everett Harris & Co’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$425K Hold
2,235
0.01% 228
2026
Q1
$377K Hold
2,235
﹤0.01% 251
2025
Q4
$377K Buy
2,235
+302
+16% +$49.1K ﹤0.01% 255
2025
Q3
$279K Hold
1,933
﹤0.01% 283
2025
Q2
$245K Hold
1,933
﹤0.01% 296
2025
Q1
$247K Hold
1,933
﹤0.01% 290
2024
Q4
$256K Hold
1,933
﹤0.01% 260
2024
Q3
$281K Hold
1,933
﹤0.01% 243
2024
Q2
$265K Hold
1,933
﹤0.01% 241
2024
Q1
$265K Hold
1,933
﹤0.01% 243
2023
Q4
$263K Hold
1,933
﹤0.01% 227
2023
Q3
$236K Hold
1,933
﹤0.01% 230
2023
Q2
$245K Hold
1,933
﹤0.01% 228
2023
Q1
$250K Sell
1,933
-102
-5% -$13.4K ﹤0.01% 230
2022
Q4
$267K Hold
2,035
﹤0.01% 223
2022
Q3
$238K Buy
2,035
+30
+1% +$3.73K ﹤0.01% 231
2022
Q2
$236K Hold
2,005
﹤0.01% 240
2022
Q1
$261K Hold
2,005
﹤0.01% 238
2021
Q4
$306K Sell
2,005
-90
-4% -$13.9K ﹤0.01% 226
2021
Q3
$339K Sell
2,095
-50
-2% -$8.41K 0.01% 212
2021
Q2
$351K Sell
2,145
-24
-1% -$3.7K 0.01% 212
2021
Q1
$327K Buy
2,169
+102
+5% +$16.2K 0.01% 214
2020
Q4
$313K Hold
2,067
0.01% 214
2020
Q3
$280K Buy
2,067
+174
+9% +$23.6K 0.01% 210
2020
Q2
$259K Buy
+1,893
New +$241K 0.01% 209

Other funds holding IBB

Everett Harris & Co's IBB Position: Q2 2026 in Review

Everett Harris & Co held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 2,235 shares worth $425K. The position accounts for 0.01% of the portfolio, ranked #228.

Everett Harris & Co first reported a position in IBB in Q2 2020 and has held it in 25 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Everett Harris & Co held 2,235 shares of iShares Biotechnology ETF worth $425K as of Q2 2026.
  • Everett Harris & Co left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.01% of Everett Harris & Co's portfolio in Q2 2026, its #228 holding.
  • Everett Harris & Co first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 25 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Everett Harris & Co's 13F filing for Q2 2026, filed 3 Aug 2026.